Nanoform financial calendar for 2023
Company Announcement Nanoform Finland Plc December 7th, 2022 11.00 a.m.…
Nanoform Q3 and 9M 2022 report: Continued solid progress
Highly promising in-vivo data for the treatment of glioblastoma multiforme…
Invitation to Nanoform’s Interim Report January-September 2022
Press release Nanoform Finland Plc November 15, 2022 11:00 a.m.…
Nanoform Finland Plc – Manager’s transactions – Niklas Sandler
Company release Nanoform Finland Plc October 27, 2022 19:15 Finnish…
TargTex to present Tumour Eradication in Rodents from its Nanoformed Glioblastoma drug
Press release Nanoform Finland Plc October 17, 2022 08:10 a.m.…
Nanoform Finland Plc – Manager’s transactions – Niklas Sandler
Company release Nanoform Finland Plc September 7, 2022 18:00 Finnish…
Share subscriptions based on Nanoform Finland Plc’s stock options 2-3/2019 and 1/2020
Company release Nanoform Finland Plc September 6, 2022 06:00 p.m.…
Nanoform Q2 and H1 2022 report: Strong momentum continues
Company Announcement Nanoform Finland Plc August 25, 2022 08:10 a.m.…